In 2020, pharma companies were forced to pivot to digital-first business models in a rapid turnaround. In just a few months, companies accelerated digitization by three to four years and accelerated the share of digital ..

The economy is a key focus on the future of nearly every industry, and digital health isn’t immune to the external pressures that determine prices, supplies, and stock ratings. But a recession, defined as a period betw..

For decades, the most popular buzzword in healthcare has been interoperable. It is the de-facto standard which all health tech components aim to achieve and are measured against. But a new focus on integrated health care..

Digital health is being implemented across the pharmaceutical value chain, integrating technologies such as apps and wearables to support decentralized clinical trials and vital sign monitoring. But opportunities to impr..

For pharma companies, digital is not an island operating independently of business strategy; it’s embedded within it. Yet 60% of pharma companies admit their digital initiatives are only partly linked to their broader ..

Do you really need another platform? At its core, interoperability is the capacity for healthcare providers to access and share patient health information and the most up-to-date and complete patient medical records, ..

Major advances in technology are driving innovation in the health care ecosystem, leading to the development of an increasing number of connected medical devices that can collect, analyze, and transmit data. That data, ..

Digital therapeutics (DTx) have been increasingly popular since smartphones and wearable tech extend their reach and support into patient’s lives. And the pandemic set them on a trajectory for massive growth and mainst..

By Omri Shor The national conference for specialty pharmaceutical industry, Asembia, took place last week and there were some standout discussions that are presenting new views into the industry ahead. Below are five ..

In the US, the role of payers has grown from a simple checks-and-balance player to ensure cost-effective treatment to one that has significant sway in the direction and advancement of new health programs. This is especia..